{"id":"https://openalex.org/W2478972716","doi":"https://doi.org/10.1007/s11864-016-0422-4","title":"Relapsed Glioblastoma: Treatment Strategies for Initial and Subsequent Recurrences","display_name":"Relapsed Glioblastoma: Treatment Strategies for Initial and Subsequent Recurrences","publication_year":2016,"publication_date":"2016-07-26","ids":{"openalex":"https://openalex.org/W2478972716","doi":"https://doi.org/10.1007/s11864-016-0422-4","mag":"2478972716","pmid":"https://pubmed.ncbi.nlm.nih.gov/27461038"},"language":"en","primary_location":{"id":"doi:10.1007/s11864-016-0422-4","doi":"https://doi.org/10.1007/s11864-016-0422-4","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11864-016-0422-4","pdf_url":null,"source":{"id":"https://openalex.org/S208090617","display_name":"Current Treatment Options in Oncology","issn_l":"1527-2729","issn":["1527-2729","1534-6277"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Treatment Options in Oncology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104022151","display_name":"Alicia Tosoni","orcid":"https://orcid.org/0000-0001-8662-7055","observed_orcids":["https://orcid.org/0000-0001-8662-7055"]},"institutions":[{"id":"https://openalex.org/I4210152184","display_name":"Ospedale Bellaria","ror":"https://ror.org/05fz2yc38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210119117","https://openalex.org/I4210152184"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alicia Tosoni","raw_affiliation_strings":["Department of Medical Oncology, Bellaria Hospital, Azienda USL-IRCCS Institute of Neurological Sciences, Via Altura 4, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Bellaria Hospital, Azienda USL-IRCCS Institute of Neurological Sciences, Via Altura 4, Bologna, Italy","institution_ids":["https://openalex.org/I4210152184"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063327760","display_name":"Enrico Franceschi","orcid":"https://orcid.org/0000-0001-9332-4677","observed_orcids":["https://orcid.org/0000-0001-9332-4677"]},"institutions":[{"id":"https://openalex.org/I4210152184","display_name":"Ospedale Bellaria","ror":"https://ror.org/05fz2yc38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210119117","https://openalex.org/I4210152184"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Enrico Franceschi","raw_affiliation_strings":["Department of Medical Oncology, Bellaria Hospital, Azienda USL-IRCCS Institute of Neurological Sciences, Via Altura 4, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Bellaria Hospital, Azienda USL-IRCCS Institute of Neurological Sciences, Via Altura 4, Bologna, Italy","institution_ids":["https://openalex.org/I4210152184"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013207477","display_name":"Rosalba Poggi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152184","display_name":"Ospedale Bellaria","ror":"https://ror.org/05fz2yc38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210119117","https://openalex.org/I4210152184"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Rosalba Poggi","raw_affiliation_strings":["Department of Medical Oncology, Bellaria Hospital, Azienda USL-IRCCS Institute of Neurological Sciences, Via Altura 4, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Bellaria Hospital, Azienda USL-IRCCS Institute of Neurological Sciences, Via Altura 4, Bologna, Italy","institution_ids":["https://openalex.org/I4210152184"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087336206","display_name":"Alba Ariela Brandes","orcid":"https://orcid.org/0000-0002-2503-9089","observed_orcids":["https://orcid.org/0000-0002-2503-9089"]},"institutions":[{"id":"https://openalex.org/I4210119117","display_name":"Azienda USL di Bologna","ror":"https://ror.org/02mby1820","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210119117"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Alba A. Brandes","raw_affiliation_strings":["Department of Medical Oncology, Bellaria Hospital, Azienda USL-IRCCS Institute of Neurological Sciences, Via Altura 4, Bologna, Italy. alba.brandes@yahoo.it","Department of Medical Oncology, Bellaria Hospital, Azienda USL\u2014IRCCS Institute of Neurological Sciences, Via Altura 4, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Bellaria Hospital, Azienda USL-IRCCS Institute of Neurological Sciences, Via Altura 4, Bologna, Italy. alba.brandes@yahoo.it","institution_ids":["https://openalex.org/I4210119117"]},{"raw_affiliation_string":"Department of Medical Oncology, Bellaria Hospital, Azienda USL\u2014IRCCS Institute of Neurological Sciences, Via Altura 4, Bologna, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5087336206"],"corresponding_institution_ids":["https://openalex.org/I4210119117"],"apc_list":{"value":4890,"currency":"USD","value_usd":4890},"apc_paid":null,"fwci":1.0385,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.77438424,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"17","issue":"9","first_page":"49","last_page":"49"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recurrent-glioblastoma","display_name":"recurrent glioblastoma","score":0.8399999737739563},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7599999904632568},{"id":"https://openalex.org/keywords/reoperation","display_name":"reoperation","score":0.800000011920929},{"id":"https://openalex.org/keywords/second-line-chemotherapy","display_name":"second-line chemotherapy","score":0.8659999966621399},{"id":"https://openalex.org/keywords/mgmt-promoter-methylation","display_name":"MGMT promoter methylation","score":0.8700000047683716},{"id":"https://openalex.org/keywords/nitrosourea-chemotherapy","display_name":"nitrosourea chemotherapy","score":0.8130000233650208},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9639999866485596},{"id":"https://openalex.org/keywords/third-line-therapy","display_name":"third-line therapy","score":0.6579999923706055},{"id":"https://openalex.org/keywords/clinical-trial-enrollment","display_name":"clinical trial recruitment","score":0.6600000262260437},{"id":"https://openalex.org/keywords/palliative-care","display_name":"palliative care","score":0.7540000081062317}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9366521239280701},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.8250794410705566},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7221307158470154},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7072441577911377},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.6545051336288452},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.6210968494415283},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6194703578948975},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5905723571777344},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5850543975830078},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5534086227416992},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5270117521286011},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.49528661370277405},{"id":"https://openalex.org/C2780147359","wikidata":"https://www.wikidata.org/wiki/Q415869","display_name":"Carmustine","level":4,"score":0.4279693365097046},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.41431349515914917},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4046473503112793},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.2719922661781311}],"mesh":[{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019233","descriptor_name":"Retreatment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s11864-016-0422-4","doi":"https://doi.org/10.1007/s11864-016-0422-4","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11864-016-0422-4","pdf_url":null,"source":{"id":"https://openalex.org/S208090617","display_name":"Current Treatment Options in Oncology","issn_l":"1527-2729","issn":["1527-2729","1534-6277"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Treatment Options in Oncology","raw_type":"journal-article"},{"id":"pmid:27461038","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27461038","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current treatment options in oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W1567412466","https://openalex.org/W1860764269","https://openalex.org/W1862835589","https://openalex.org/W1887747927","https://openalex.org/W2013247986","https://openalex.org/W2020425801","https://openalex.org/W2052491055","https://openalex.org/W2064214863","https://openalex.org/W2075528869","https://openalex.org/W2082685970","https://openalex.org/W2086216067","https://openalex.org/W2092618575","https://openalex.org/W2093783077","https://openalex.org/W2096287682","https://openalex.org/W2098867019","https://openalex.org/W2099541268","https://openalex.org/W2100673960","https://openalex.org/W2110141288","https://openalex.org/W2114279513","https://openalex.org/W2123808042","https://openalex.org/W2127745545","https://openalex.org/W2132697290","https://openalex.org/W2135783949","https://openalex.org/W2143476979","https://openalex.org/W2144487043","https://openalex.org/W2146218807","https://openalex.org/W2152323728","https://openalex.org/W2153384261","https://openalex.org/W2154303411","https://openalex.org/W2155514088","https://openalex.org/W2160959204","https://openalex.org/W2162119542","https://openalex.org/W2163264715","https://openalex.org/W2165772224","https://openalex.org/W2170367762","https://openalex.org/W2170965589","https://openalex.org/W2207707220","https://openalex.org/W2217242371","https://openalex.org/W2232686527","https://openalex.org/W2239268806","https://openalex.org/W2263547530","https://openalex.org/W2272888082","https://openalex.org/W2275199929","https://openalex.org/W2286503151","https://openalex.org/W2302516330","https://openalex.org/W2318368210","https://openalex.org/W2325421340","https://openalex.org/W2344682920","https://openalex.org/W2472428875","https://openalex.org/W2747881734","https://openalex.org/W2804663253","https://openalex.org/W4242380496","https://openalex.org/W4243374657"],"related_works":["https://openalex.org/W7125769673","https://openalex.org/W1881534971","https://openalex.org/W2279568831","https://openalex.org/W4200249901","https://openalex.org/W2121396361","https://openalex.org/W2999877815","https://openalex.org/W1988011020","https://openalex.org/W2162913015","https://openalex.org/W4296009079","https://openalex.org/W4318934328"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":8},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-08-23T00:00:00"}